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Naive T cells respond to antigens by differentiating
into effector and regulatory lineages. Whereas the
roles of T cell-intrinsic pathways have been exten-
sively studied, how T cell lineage choices are
controlled by innate immune signals remains elusive.
Here we report that dendritic cell (DC)-expressed
phosphatase MKP-1, a negative regulator of the
MAP kinases, programmed reciprocal T helper 1
(Th1) and Th17 cell differentiation by modulating
IL-12-STAT4 and IL-6-STAT3 axes and cytokine
receptor expression at the DC-T cell interface.
MKP-1 was regulated by innate recognition signals
and its deficiency disrupted antimicrobial responses
and promoted T cell-mediated inflammation. More-
over, MKP-1 inhibited induction of regulatory T cells
by downregulating TGF-b2 production from DCs.
Our findings identify a regulatory circuit linking
MKP-1 signaling in DCs, production of polarizing
cytokines, and integration of DC-derived signals in
responding T cells, that bridges innate and adaptive
immunity to coordinate protective immunity and
immunopathology.
INTRODUCTION
Naive CD4+ T cells respond to antigen stimulation by differenti-
ating into diverse lineages, including T helper 1 (Th1), Th2, and
Th17 cells, to attain specialized properties and effector func-
tions. Naive precursors also develop into antigen-specific
Foxp3+ regulatory T (Treg) cells, known as ‘‘induced Treg (iTreg)
cells’’ to counterbalance effector T cell functions (Zhu et al.,
2010). Emerging evidence suggests a greater complexity in
T cell lineage commitment and plasticity, especially among
iTreg, Th17, and Th1 cells, than previously appreciated. First,
iTreg cells share circuitry with Th17 cells, because the differenti-
ation of both lineages relies on the pleiotropic cytokine TGF-b
(Zhu et al., 2010). Second,many effector T cells at sites of inflam-
mation coexpress IFN-g and IL-17, and recent evidence
supports plasticity in the Th17 cell lineage, with the potential to
evolve into IFN-g-expressing cells (Bending et al., 2009; Leeet al., 2009; Martin-Orozco et al., 2009). Thus, unlike Th1 and
Th2 cells, the relationship of Th1 and Th17 cells is not limited
to cross-inhibition but involves a potential for ongoing generation
of effector cells with a changing ormixed phenotype. Third, naive
T cells can engage reciprocal developmental pathways to
generate iTreg and Th1 cells, in a process dependent upon the
antagonistic interaction between the G protein-coupled receptor
S1P1 and TGF-b signaling (Liu et al., 2010). Despite extensive
progress, it remains poorly understood how the differentiation
of naive precursors into opposing lineages is regulated. In partic-
ular, because many of the studies rely on the use of cytokine
supplement or ablation, how T cell lineage commitment and
plasticity are coordinated by physiological stimuli remains to
be established.
Dendritic cells (DCs) are the most important cell type to bridge
innate and adaptive immunity (Iwasaki and Medzhitov, 2010;
Joffre et al., 2009). DCs express a repertoire of pattern recogni-
tion receptors (PRRs) that sense microbial pathogens to initiate
a signaling cascade culminating in the activation of DCs. Acti-
vated DCs present peptide antigens, upregulate costimulatory
molecules, and produce cytokines, collectively known as signals
1, 2, and 3, that act on responding T cells to promote their acti-
vation and differentiation (Joffre et al., 2009).
Although DCs and other innate immune cells serve as antigen-
presenting cells (APCs) to regulate T cell responses, they also
contribute to a PRR-induced acute inflammatory response that
provides first-line protection against invading pathogens. Devel-
opment of adaptive immunity is considerably slower than the
acute inflammatory response because it requires functional
activation of DCs before they can efficiently prime naive T cells
(Medzhitov,2007).However, aprolonged inflammatory response,
although beneficial to promoting adaptive immunity, could be
dangerous to the host by causing overt inflammation and tissue
damage.Thus,botheffectsof innate recognitionmustbeproperly
regulated to instruct an effective antigen-specific response to
pathogens while simultaneously constraining potential damage
to the host. We speculate that PRR-triggered effects on acute
inflammation and induction of adaptive immunity might be coor-
dinately regulated at the molecular level. To this end, we deter-
mined whether the phosphatase MKP-1 (encoded by Dusp1),
a central negative regulator of Toll-like receptor (TLR)-induced
innate immune responses (Chi et al., 2006; Hammer et al., 2006;
Salojin et al., 2006; Zhao et al., 2006), cross-regulates adaptive
immunity. MKP-1 is a prototypic phosphatase in the dual-speci-
ficity phosphatase (DUSP) family that dephosphorylates andImmunity 35, 45–58, July 22, 2011 ª2011 Elsevier Inc. 45
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MKP-1 in DCs Instructs T Cell DifferentiationinactivatesMAP kinases (MAPKs).MKP-1 is rapidly induced after
TLR stimulation, and Dusp1/ macrophages exhibit increased
activation of p38 and JNK. Dusp1 deficiency results in excessive
production of proinflammatory cytokines and susceptibility to
endotoxic shock, highlighting a critical role for MKP-1 in restrain-
ing innate inflammation (Chi et al., 2006; Hammer et al., 2006;
Salojin et al., 2006; Zhao et al., 2006).
Here we report that MKP-1 bridges innate and adaptive
immunity by programming DC-derived signal 3 for T cell lineage
determination. MKP-1 in DCs directed reciprocal differentiation
between Th17 and Th1 cells by differentially regulating IL-12
and IL-6 production inDCs and imprinting distinct STAT signaling
and cytokine receptor expression in responding T cells. MKP-1
expression was regulated by innate stimuli that correlated with
the capacity of these conditions to promote selective T cell differ-
entiation, highlighting a key physiological role for MKP-1 to inte-
grate innate signals in DCs. Moreover, MKP-1 suppressed the
expression of TGF-b2and IL-10expression inDCsandcontrolled
DC-dependent iTreg cell generation. The differentiation capac-
ities of Th1, Th17, and iTreg cells are all dependent upon a single
pathway in DCs, so our studies indicate that lineage commitment
and plasticity among the three populations are coordinated by
DCs to balance protective and harmful immunity.
RESULTS
InnateMKP-1SignalingDirects Antibacterial and Fungal
Th1 and Th17 Cell Responses
To investigate how innate immune signaling directs effector
T cell responses, we first measured in vivo differentiation of
T cells after antigen stimulation in the presence of different
adjuvants. TLR ligands are classically considered to induce
IFN-g-producing Th1 cells (Medzhitov, 2007; Palm and Medzhi-
tov, 2009), whereas Dectin-1, a C-type lectin specific for
b-glucans, induces T cell responses toward the Th17 cell lineage
(LeibundGut-Landmann et al., 2007). Therefore, we compared
the in vivo adjuvant activity of LPS, a widely used ligand for
TLR4, and curdlan, a prototypic agonist for Dectin-1. Consistent
with previous observations in vitro (Iezzi et al., 2009), curdlan
induced a considerably stronger Th17 cell responses in vivo as
compared with LPS (see Figure S1A available online). Because
DCs are themost potent APCs at priming naive T cells, we exam-
ined signaling pathways in wild-type (WT) splenic DCs. LPS and
curdlan stimulation in vivo led to differential expression of MKP-1
(Figure 1A). OtherMKPs implicated in immune functions, such as
MKP-2 and MKP-5 (Al-Mutairi et al., 2010; Zhang et al., 2004),
did not show selective regulation in response to LPS and curdlan
(Figure 1A). Consistent with the in vivo observations, expression
and phosphatase activity of MKP-1 were more prominently
upregulated by LPS than by curdlan (Figures S1B and S1C).
Moreover, MKP-1 phosphorylation, indicative of its stabilization
(Brondello et al., 1999), was strongly induced by LPS (Fig-
ure S1B). These results collectively indicate a likely involvement
of MKP-1 in integrating innate signals in DCs to instruct T cell
differentiation.
To bypass the intrinsic requirement of MKP-1 in T cell activa-
tion (Zhang et al., 2009), we selectively eliminated MKP-1
expression in bone marrow (BM)-derived innate immune cells
via mixed BM chimeras. To this end, we transferred a 5:1 ratio46 Immunity 35, 45–58, July 22, 2011 ª2011 Elsevier Inc.of Dusp1/Rag1/ (CD45.1.1) and WT (CD45.1.2, ‘‘spike’’)
BM cells into lethally irradiated CD45.2.2 recipients
(Dusp1/Rag1/ + spike/WT; named ‘‘KO chimeras’’ here-
after); as a control, we also transferred Rag1/ and WT spike
BM cells at a 5:1 ratio (Rag1/ + spike / WT; named ‘‘WT
chimeras’’ hereafter) (Figure S1D). Because Rag1/ mice did
not contain lymphocytes, all T cells in the chimeras were derived
from WT spike BM cells, whereas the majority of innate immune
cells either lacked or contained MKP-1 in the experimental or
control group, respectively (Figure S1D).
To analyze whether MKP-1 functions in innate immune cells to
regulate adaptive immunity, we challenged the chimeric mice
with Gram-positive bacteria Listeria monocytogenes, a proto-
typic model eliciting a strong Th1 cell-polarized response. At day
7–8 after infection, splenocytes were stimulated with phorbol
12-myristate 13-acetate (PMA) and ionomycin or an immunodo-
minant peptide LLO189201. Under both conditions, T cells
(derived from the spike BM) in the KO chimeras contained
a greatly reduced proportion of IFN-g+ cells but a significantly
increased IL-17+ population as compared with those in the WT
chimeras (Figures 1B and 1C). Upon ex vivo LLO stimulation,
splenocytes from the KO chimeras expressed lower IFN-g but
higher IL-17 mRNA (Figure 1D). Therefore, MKP-1 deficiency in
innate immune cells promotes Th17 cell but diminishes Th1
cell response during bacterial infection.
We next challenged the chimeras with Candida albicans,
a fungal infectious model known to induce a strong Th17 cell
response (Netea et al., 2008). At day 7–8 after infection, spleno-
cytes were stimulated with heat-killed C. albicans extracts, and
secreted IFN-g and IL-17 were measured. As compared with
WT chimeras, KO chimeras produced about 1/3 of IFN-g but
2-fold more IL-17 (Figure 1E). Taken together, we conclude
that lack of MKP-1 in innate immune cells results in an altered
balance of Th1 and Th17 cell responses against microbial
infections.
Innate MKP-1 Instructs Reciprocal Th1 and Th17 Cell
Differentiation In Vivo
A role for innate MKP-1 signaling to regulate antimicrobial Th1
and Th17 cell responses prompted us to investigate whether
it controls antigen-specific T cell differentiation. To this end,
naive T cells (CD62LhiCD44loCD25) from OT-II TCR-transgenic
mice (specific for OVA323-339; Thy1.1
+) were transferred into WT
and Dusp1/ mice, followed by immunization with antigen
emulsified in CFA. At day 7–8 after immunization, draining lymph
node (DLN) cells were stimulated with OVA ex vivo for 2–3 days.
T cells derived from WT and Dusp1/ hosts proliferated to
a similar degree (Figure 2A). However, the secreted IFN-g
amounts were diminished whereas IL-17 increased in T cells
obtained from the immunized Dusp1/ hosts (Figure 2B). Other
cytokines such as IL-4 and IL-2 were comparable between the
two groups (data not shown). To directly examine differentiation
of donor-derived cells, we analyzed the distribution of IFN-g+
and IL-17+ populations. As compared with donor cells in the
WT recipients, those in the Dusp1/ recipients contained
reduced frequency of IFN-g+ cells but increased percentage of
IL-17+ population (Figure 2C). Thus, MKP-1 deficiency leads to
an altered balance of antigen-induced Th1 and Th17 cell
populations.
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Figure 1. Innate MKP-1 Signaling Determines the Balance of Th1 and Th17 Cell Responses in Bacterial and Fungal Infections
(A) LPS and curdlan differentially regulate MKP-1 expression in DCs in vivo. C57BL/6 mice were injected with LPS or curdlan i.p., and expression of MKP-1,
MKP-2, and MKP-5 in splenic DCs was examined by real-time PCR analysis (levels in unstimulated DCs were set to 1).
(B–E) Mixed BM chimeras containing WT lymphocytes (‘‘spike’’) andWT or Dusp1/ innate immune cells were generated as described in Figure S1D. Error bars
indicate SEM.
(B–D) Chimeras were infected with L. monocytogenes.
(B and C) After 7–8 days, expression of IFN-g and IL-17 in spike-derived T cells in the spleen was determined by intracellular staining after stimulation with
PMA-ionomycin (B) or LLO189201 (C). The proportions of IL-17
+ and IFN-g+ populations in spike-derived T cells are indicated in the right of each panel.
(D) Analysis of cytokine mRNA expression in splenocytes after stimulation with LLO for 48 hr.
(E) Chimeras were infected withC. albicans. After 7–8 days, splenocytes were stimulated with heat-killedC. albicans for 48 hr, and secreted IFN-g and IL-17 were
measured. Each symbol represents an individual mouse and small horizontal lines indicate the mean.
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MKP-1 in DCs Instructs T Cell DifferentiationTo ensure that the effect of MKP-1 on T cell responses is not
restricted to a specific type of antigen-specific T cells, we used
T cells from a second TCR-transgenic model—the 2D2 trans-
genic mice that recognize the MOG35-55 peptide (Bettelli
et al., 2003). Upon transfer and immunization, 2D2 T cells
developed into a reduced Th1 but increased Th17 cell popula-
tion in the Dusp1/ hosts relative to WT hosts (Figure 2D).
Also, T cells from the Dusp1/ hosts expressed lower IFN-g
but higher IL-17 mRNA upon ex vivo peptide stimulation (Fig-ure 2E). Thus, MKP-1 cross-regulates antigen-specific T cell
differentiation.
We next identified the cell type in which MKP-1 functions to
instruct T cell responses. Given the expression pattern of
MKP-1 in DCs (Figure 1A), we examined whether MKP-1 defi-
ciency affects development or homeostasis of DCs. WT and
Dusp1/ mice contained similar distributions of CD11c+ DCs
as well as CD8a+, CD11b+, andmPDCA-1+ subsets in the spleen
and other lymphoid organs (Figure S2A and data not shown).Immunity 35, 45–58, July 22, 2011 ª2011 Elsevier Inc. 47
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Figure 2. Innate MKP-1 Signaling Cross-regulates Reciprocal Th1 and Th17 Cell Differentiation In Vivo
(A–C) Naive OT-II T cells (Thy1.1+) cells were transferred into WT and Dusp1/ mice and immunized with OVA+CFA. DLN cells were analyzed 7–8 days later.
(A) Proliferation of DLN cells after ex vivo stimulation with OVA for 72 hr.
(B) Secreted IFN-g and IL-17 after stimulation with 5 mg/ml OVA for 72 hr.
(C) Expression of IFN-g and IL-17 in donor-derived (Thy1.1+) T cells after PMA-ionomycin stimulation. Right, the proportions of IL-17+ and IFN-g+ populations
among donor cells.
(D and E) Naive MOG-transgenic 2D2 T cells (Thy1.1+) were transferred into WT and Dusp1/ mice and immunized with MOG+CFA. DLN cells were analyzed
7–8 days later.
(D) Expression of IFN-g and IL-17 in donor-derived (Thy1.1+) T cells. Right, the proportions of IL-17+ and IFN-g+ populations among donor T cells.
(E) Analysis of IFN-g and IL-17 mRNA in DLN cells after stimulation with MOG for 48 hr.
(F and G) Naive OT-II T cells (Thy1.1+) cells were transferred into WT mice, followed by immunization with WT or Dusp1/ DCs pulsed with LPS and OVA.
(F) Expression of IFN-g and IL-17 in donor-derived cells. Right, the proportion of IFN-g+ population among donor cells.
(G) Analysis of IL-17 mRNA in DLN cells after stimulation with 5 mg/ml OVA for 48 hr.
(H and I) T cells (CD4+CD45RBhiCD25) were transferred into Rag1/ and Dusp1/Rag1/ mice, and body weight was measured weekly (H). Expression of
IFN-g and IL-17 from donor cells was analyzed in the MLNs (I).
Data are representative of two (A–C, F, G) or four (D, E, H, I) independent experiments (five mice per group). Error bars indicate SEM. See also Figure S2.
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Immunity
MKP-1 in DCs Instructs T Cell DifferentiationExpression of costimulatorymolecules CD80 andCD86was also
comparable between WT and Dusp1/ DCs (Figure S2B). To
examine the effects of MKP-1 deficiency on DC-mediated
T cell responses in vivo, we stimulated WT and Dusp1/ DCs
with OVA and LPS and transferred them into WT mice that
received naive OT-II T cells the day before. At day 7–8 after
DC transfer, donor T cells were analyzed for the expression of
IFN-g and IL-17. Development of IFN-g+ cells was significantly
reduced in T cells stimulated with Dusp1/ DCs (Figure 2F).
Under these conditions, IL-17+ population was not detectable
by intracellular staining, but real-time PCR analysis revealed
augmented IL-17 mRNA in the Dusp1/ DC transfer group (Fig-
ure 2G). These results indicate an important role for MKP-1 in
DCs to direct T cell differentiation.
To determine the in vivo significance of MKP-1-dependent
T cell differentiation, we used a T cell model of colitis by transfer-
ringCD45RBhiCD25 T cells intoRag1/ andDusp1/Rag1/
mice. As compared with the gradual weight loss in Rag1/
recipients, Dusp1/Rag1/ recipients exhibited markedly
accelerated weight loss (Figure 2H). At week 4 after transfer,
whereas Rag1/ recipients lost 10% of their body weight,
Dusp1/Rag1/ recipients lost more than 25% of their weight.
To dissect the underlyingmechanisms, wemeasured expression
of IFN-g and IL-17 in donor cells populating themesenteric lymph
nodes (MLNs). As compared with donors in the Rag1/ recipi-
ents, those in the Dusp1/Rag1/ mice contained more
IL-17+ cells but a reduced IFN-g+ population (Figure 2I).
Altogether, MKP-1 acts in the innate immune compartment to
control the reciprocal development of Th1 and Th17 cells in vivo.
MKP-1 Programs DC-Mediated Th1 and Th17 Cell
Differentiation
Whereas the in vivo systems described above revealed func-
tional importance of MKP-1 in the innate immune compartment,
especially DCs, in cross-regulating CD4+ T cell responses, they
do not allow the assessment of direct DC-T cell interaction.
Therefore, we established highly purified in vitro systems by co-
culturing naive OT-II T cells with WT or Dusp1/ splenic DCs in
the presence of LPS and OVA, without any exogenous cytokine
added, to model the physiological interaction between DCs and
T cells. Under these conditions, proliferation and survival of
T cells were comparable when stimulated with WT or Dusp1/
DCs (Figures S3A and S3B). After 5 days of culture, live T cells
were restimulated for cytokine analysis. T cells activated with
Dusp1/ DCs secreted less IFN-g but more IL-17 (Figure 3A),
associated with a significantly higher percentage of IL-17+ cells
and a lower frequency of IFN-g+ cells (Figure 3B), indicating an
altered balance of Th1 and Th17 cell differentiation. Real-time
PCR analysis showed that in addition to the expected changes
in IFN-g and IL-17 mRNA expression, expression of other Th17
cell family cytokines (IL-17F, IL-21, and IL-22) was also
increased in T cells activated with Dusp1/ DCs. In contrast,
expression of IL-2 and IL-4 was comparable between the two
groups (Figure 3C). Consistent with a diminished ability to
mediate Th1 cell differentiation, Dusp1/ DCs were deficient
to upregulate the Th1 cell surface marker CXCR3 in T cells (Fig-
ure 3D). In addition, T cells culturedwithDusp1/DCs activated
with other innate stimuli showed similar alterations in Th1 and
Th17 cell differentiation (Figure S3C), indicating that MKP-1integrates PRR signals in DCs to control T cell responses. More-
over, when Dusp1/ DCs were incubated with polyclonal naive
T cells and a-CD3, Th1 and Th17 cell differentiation was also
altered (Figure 3E). Thus, Dusp1/ DCs induce reciprocal
changes in the developmental programs of Th1 and Th17 cells.
We next determined the kinetics and mechanisms for the
altered Th1 and Th17 cell differentiation induced by Dusp1/
DCs by analyzing gene expression in T cells activated at various
time points (Figure 3F). T cells cultured withWTDCs upregulated
IFN-g, IL-17, and IL-17F, whereas those activated withDusp1/
DCs showed considerable reduction of IFN-g but stronger upre-
gulation of IL-17 and IL-17F. Notably, marked differences in
cytokine expression induced by these two types of DCs were
apparent only after 24 hr of stimulation, suggesting a likely
involvement of DC-derived polarizing cytokines (Avni et al.,
2002). Expression of IL-21 was upregulated even earlier upon
stimulation with Dusp1/ DCs, consistent with the role of the
autocrine cytokine to potentiate Th17 cell differentiation (Zhu
et al., 2010). Polarization of Th1, Th2, and Th17 cells is largely
driven by lineage-specific transcription factors (Zhu et al.,
2010). As compared with WT DCs, Dusp1/ DCs induced
lower expression of T-bet and Eomes in T cells (Figure 3F). In
contrast, expression of RORa, but not other Th17 cell-related
transcription factors (RORgt, AHR, and IRF4), was upregulated
in T cells cultured with Dusp1/ DCs, indicative of a selective
effect on the Th17 cell differentiation program. Expression
of the Th2 cell regulator GATA3 and follicular T cell factor
BCL6 was not affected in T cells stimulated with Dusp1/
DCs (Figure 3F and data not shown). Thus, MKP-1 acts directly
in DCs to program the alternative cell fates between Th1 and
Th17 cells.
MKP-1-Dependent Cytokine Release Regulates Th1
and Th17 Cell Differentiation
We next determined the cellular mechanisms by which MKP-1
regulates DC-mediated Th1 and Th17 cell differentiation. WT
and Dusp1/ DCs expressed comparable amounts of CD86
and CD80 before and after in vivo LPS stimulation (Figure 4A;
Figure S2B). We next measured cytokines known to regulate
Th1 and Th17 cell differentiation, including IL-6 and IL-12 that
have been shown to be altered in Dusp1/ BM-derived DCs
in vitro (Zhao et al., 2006). Intracellular staining showed that
IL-12 p40 was significantly reduced in Dusp1/ DCs, while
expression of IL-6 was increased (Figure 4B). These alterations
occurred in both subsets of CD8a+ and CD11b+ Dusp1/ DCs
(Figure S4A). The changes in cytokine production were associ-
ated with altered mRNA expression of IL-6 and IL-12 p40 after
LPS stimulation in vitro (Figure 4C) and in vivo (Figure 4D). By
contrast, expression of IL-12 p35 and IL-23 p19 was not signifi-
cantly altered in Dusp1/ DCs (data not shown). Moreover,
phosphorylation of STAT4, a downstream target for IL-12 in
T cells, was diminished after they were activated with Dusp1/
DCs, further indicating defective IL-12 release from Dusp1/
DCs (Figure 4E). In contrast, STAT3 phosphorylation was
enhanced in T cells activated with Dusp1/ DCs (Figure 4E),
consistent with the increased IL-6 synthesis. Altogether, MKP-
1 deficiency in DCs results in altered production of IL-6 and
IL-12 and the accompanying changes in STAT activation in
responding T cells.Immunity 35, 45–58, July 22, 2011 ª2011 Elsevier Inc. 49
WT
Dusp1–/–
ED
CXCR3
Isotype
Dusp1–/–
F
BA
IL
-
17
IFN-γ
WT
p=0.036
p=0.045
IFN
-
γ
IL-
17
pg
/m
l
R
el
at
iv
e
 
ge
n
e
 e
xp
re
ss
io
nC
p=0.002
p=0.007
IF
N-
γ
IL
-1
7
%
 o
f C
D4
+
T 
ce
lls
 
p=0.001 p=0.003
IF
N
-γ
+
o
f C
D4
+
T 
ce
lls
 (%
)
IL
-
17
+
o
f C
D4
+
T 
ce
lls
 (%
)
W
T
D
u
s
p
1
–
/–
0.28 0.15
24.675
1.28 0.33
1484.4
R
el
at
iv
e 
CX
CR
3 
e
xp
re
ss
io
n
Time after coculture (days)
Time after coculture (days)
R
el
at
iv
e
 g
en
e 
ex
pr
es
sio
n
WT
Dusp1–/–
WT
Dusp1–/–
WT
Dusp1–/–
WT
Dusp1–/–
WT
Dusp1–/–
W
T
D
u
s
p
1
–
/–
IFN-γ IL-17 IL-17F IL-21 IL-22 IL-2 IL-4
IFN-γ IL-17 IL-17F IL-21 IL-22 T-bet
Eomes RORα RORγt IRF4 AHR GATA3
Figure 3. MKP-1 Acts in DCs to Instruct Th1 and Th17 Cell Differentiation In Vitro
(A–D) Naive OT-II T cells were stimulated with antigen and WT or Dusp1/ DCs for 5 days, followed by additional analyses.
(A) Secreted IFN-g and IL-17 levels in T cells restimulated with a-CD3 overnight.
(B) Intracellular staining of IFN-g and IL-17 in cultured T cells. Right, the proportions of IFN-g+ and IL-17+ proportions in CD4+ T cells.
(C) Analysis of cytokine mRNA expression in T cells restimulated with a-CD3 for 5 hr.
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Immunity
MKP-1 in DCs Instructs T Cell DifferentiationWe then determined the functional significance of MKP-1-
dependent regulation of cytokines in DCs, and whether control
of Th1 and Th17 cell differentiation by MKP-1 is interdependent.
First, to test the effects of diminished IL-12 production by
Dusp1/ DCs, we added exogenous IL-12 to DC-T cell
cocultures. IL-12 restored the reduced Th1 cell differentiation
induced by Dusp1/ DCs (Figure 4F). Th17 cell generation
was inhibited by exogenous IL-12, consistent with the inhibitory
role of IL-12 on Th17 cell differentiation (Zhu et al., 2010). To
further test the contribution of IL-12 to T cell differentiation,
we crossed Dusp1/ mice with those lacking IL-12 p35 to
ablate IL-12 but not IL-23 function (Il12a/) (Mattner et al.,
1996). As expected, loss of IL-12 in DCs decreased Th1 cell
differentiation, comparable to the defect in Dusp1/ DCs.
Moreover, Dusp1/Il12a/ DCs were similar to Il12a/ and
Dusp1/ DCs in their deficiency to mediate Th1 cell generation,
but retained the enhancedTh17cell-inducing ability (Figure S4B).
From these two complementary approaches, we conclude that
diminished IL-12 production in Dusp1/ DCs contributes to
the impaired Th1 cell development.
Second, to ascertain whether hyperproduction of IL-6 in
Dusp1/ DCs accounts for the increased Th17 cell differentia-
tion, we used a blocking antibody for IL-6. Such treatment
blocked the increased IL-17 production induced by Dusp1/
DCs, although IFN-g production was not affected (Figure 4G).
Therefore, MKP-1-mediated Th17 cell differentiation depends
upon IL-6. Further, since abrogation of IL-12 and IL-6 functions
uncoupled MKP-1-dependent controls of Th1 and Th17 cell
generation, these two effects do not appear to be interdepen-
dent, thereby supporting the reciprocal nature for the generation
of these two lineages. These results further indicate that MKP-
1-dependent IL-6 and IL-12 ratio in DCs is a key determinant
of Th17 versus Th1 cell-inducing ability. Indeed, associated
with its capacity to promote Th17 cell development and to down-
regulate MKP-1 expression, curdlan stimulation resulted in
a higher IL-6/IL-12 ratio, relative to LPS (Figure S4C), highlighting
the physiological significance of MKP-1-mediated pathway in
the innate and adaptive crosstalk.
Third, one of the most profoundly regulated cytokines by
MKP-1 in macrophages is the immunosuppressive cytokine
IL-10 (Chi et al., 2006). Increased IL-10 expression was observed
in Dusp1/ DCs after in vitro and in vivo simulation with LPS
(Figure S4D). To test the role of IL-10 in MKP-1-dependent
DC-T cell crosstalk, we generated Dusp1/Il10/ mice.
Compared with Il10/ DCs, Dusp1/Il10/ DCs showed an
increased ability to drive Th17 cell differentiation and reduced
activity for Th1 cell generation (Figure S4E), similar to the effects
of Dusp1 deficiency in an Il10+/+ background. In addition, block-
ing IL-10 and IL-10R function failed to rectify the altered T cell
differentiation induced by Dusp1/ DCs (data not shown).
Therefore, although MKP-1 markedly downregulates IL-10
expression in DCs, IL-10 does not contribute significantly to
MKP-1-dependent Th1 and Th17 cell differentiation.(D) Surface and mRNA expression of CXCR3.
(E) Naive T cells from C57BL/6 mice were stimulated with a-CD3 and WT or Dus
(F) Kinetic analysis of cytokine and transcription factor mRNA in OT-II T cells stim
Data are representative of five (A–D) and two (E, F) independent experiments (atMKP-1-p38 Signaling Axis Regulates IL-6 and IL-12
Expression
Having shown that MKP-1 differentially regulates IL-6 and IL-12
in DCs, we next sought to determine the biochemical mecha-
nisms involved. Although MKP-1 is capable of inactivating p38
and JNK in BM-derived macrophages, its role in primary DCs
is unknown. To identify the physiological roles of MKP-1 in
DCs, we analyzed splenic DCs from WT and Dusp1/ mice.
LPS caused activation of p38, JNK, and ERK MAPKs in WT
DCs.Dusp1/ DCs exhibited stronger and more sustained acti-
vation of p38, and to a lesser extent, JNK. ERK activation in
Dusp1/ was slightly reduced (Figure 5A). To test whether the
increased p38 and JNK activities contribute to cytokine regula-
tion, we pretreated WT and Dusp1/ DCs with SB203580 and
SP600125, the specific p38 and JNK inhibitors, respectively, fol-
lowed by LPS stimulation. At the dose used, SB203580 had very
modest effects on cytokine production from WT DCs. In
contrast, SB203580 treatment of Dusp1/ DCs increased
IL-12 and reduced IL-6 expression and restored the levels of
these cytokines similar to WT cells (Figure 5B). In contrast,
SP600125 did not affect IL-12 or IL-6 expression in WT or
Dusp1/ DCs (Figure S5). Thus, p38 mediates MKP-1 effects
on IL-6 and IL-12 expression.
IL-12Rb2 and IL-23R Expression on T Cells Integrates
MKP-1 Signaling from DCs
Our studies thus far indicate that the MKP-1-p38 axis mediates
DC-T cell crosstalk by inducing reciprocal changes in IL-12-
STAT4 and IL-6-STAT3 signaling and consequently differential
effects on Th1 and Th17 cell differentiation. However, it remains
unclear how T cells integrate DC signals to differentiate into Th1
and Th17 cells. Development of Th1 and Th17 cells requires
cytokine receptor components IL-12Rb2 and IL-23R, which
pair with IL-12Rb1 to constitute functional IL-12 and IL-23
receptors, respectively (Zhu et al., 2010). Expression of these
receptors is induced by polarizing cytokines that in turn confers
enhanced responsiveness to cytokines to potentiate T cell differ-
entiation in a feed-forward manner (Zhu et al., 2010). We found
that T cells differentiated with WT and Dusp1/ DCs expressed
comparable amounts of IL-12Rb1mRNA (Figure 6A). In contrast,
T cells activated withWT DCs upregulated IL-12Rb2 expression,
but this upregulation was considerably reduced in those acti-
vated with Dusp1/ DCs. Moreover, expression of IL-23R was
more strongly induced in T cells cultured with Dusp1/ DCs,
whereas IL-6Ra expression was not altered (Figure 6A). There-
fore, the reciprocal changes in Th1 and Th17 cell differentiation
correlated with diminished IL-12Rb2 but increased IL-23R
expression induced by Dusp1/ DCs.
Are the changes in cytokine receptor expression functionally
important? We first used T cells lacking IL-12Rb2 (Il12rb2/)
(Wu et al., 2000) and activated them with WT and Dusp1/
DCs. As compared with Il12rb2+/+ T cells, Il12rb2/ T cells
produced reduced amount of IFN-g regardless of the type ofp1/ DCs for 5 days, followed by intracellular staining.
ulated with WT or Dusp1/ DCs for different times.
least four mice per group). Error bars indicate SEM. See also Figure S3.
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Figure 4. MKP-1-Dependent IL-12 and IL-6 Production in DCs Regulates Th1 and Th17 Cell Differentiation
(A) Expression of CD80 and CD86 on WT and Dusp1/ splenic DCs after in vivo LPS stimulation for 5 hr.
(B) Expression of IL-12 p40 and IL-6 in WT and Dusp1/ splenic DCs after in vitro LPS stimulation for 5 hr. Right, the proportions of IL-12 p40+ and IL-6+
populations among CD11c+ cells.
(C and D) Analysis of IL-12 p40 and IL-6 mRNA in WT and Dusp1/ splenic DCs after LPS stimulation in vitro (C) and in vivo (D).
(E) Activation of STAT3 and STAT4 in T cells stimulated with WT or Dusp1/ DCs for 2–3 days.
(F) Expression of IFN-g and IL-17 in T cells stimulated with WT or Dusp1/ DCs in the absence or presence of 1 ng/ml IL-12. Right, the proportion of IFN-g+
population in CD4+ T cells.
(G) Expression of IFN-g and IL-17 in T cells stimulated with WT or Dusp1/ DCs in the absence or presence of a-IL-6 blocking antibody. Right, analysis of IL-17
mRNA expression.
Data are representative of four (A–C, E), three (D), and two (F, G) independent experiments (at least four mice per group). Error bars (B–D, F, G) indicate SEM. See
also Figure S4.
Immunity
MKP-1 in DCs Instructs T Cell DifferentiationDCs used. By contrast, the increased IL-17 expressionmediated
by Dusp1/ DCs was not affected by IL-12Rb2 deficiency in
T cells (Figure 6B). Thus, IL-12Rb2 expression in T cells selec-52 Immunity 35, 45–58, July 22, 2011 ª2011 Elsevier Inc.tively mediates MKP-1-dependent signals from DCs to regulate
Th1 cell differentiation. Second, we evaluated the roles of IL-23R
by adding an IL-23R blocking antibody to the coculture systems.
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Figure 5. MKP-1 Regulates IL-6 and IL-12 Expression in DCs by Inactivating p38 MAPK
(A) Activation of MAPKs in WT and Dusp1/ splenic DCs stimulated with LPS. Asterisk indicates nonspecific bands.
(B) Intracellular staining of IL-12 p40 and IL-6 inWT andDusp1/ splenic DCs pretreated with SB203580 (10 mM) for 0.5–1 hr and then stimulated with LPS. Right,
the proportions of IL-12 p40+ and IL-6+ populations in DCs. Error bars indicate SEM.
Data are representative of two independent experiments (at least four mice per group). See also Figure S5.
Immunity
MKP-1 in DCs Instructs T Cell DifferentiationBlocking IL-23R did not affect Th1 cell differentiation but blocked
the enhanced Th17 cell differentiation induced byDusp1/DCs
(Figure 6C).We conclude that IL-12Rb2 and IL-23R expression in
T cells integrates MKP-1 signaling in DCs to contribute to Th1
and Th17 cell differentiation, respectively.
MKP-1 Inhibits TGF-b2 Expression in DCs and iTreg Cell
Differentiation
Given a key role for MKP-1 to instruct DC-mediated Th1 and
Th17 but not Th2 effector cell differentiation, we further explored
whether MKP-1 regulates iTreg cell generation with two in vivo
models. First, we adoptively transferred naive OT-II T cells into
WT and Dusp1/ hosts, followed by OVA immunization. Under
these conditions, a small subset (4%) of donor cells was induced
to express Foxp3 in the WT recipients, whereas 13% of T cells
became Foxp3+ in the Dusp1/ hosts (Figure 7A). Expressionof Foxp3 and CTLA4 mRNA was upregulated accordingly (Fig-
ure 7B). Second, we used a model of oral antigen-induced iTreg
cell generation by feeding the recipients with the antigen in the
drinking water after adoptive transfer (Coombes et al., 2007;
Liu et al., 2010; Sun et al., 2007). Donor cells developed into
a significantly larger Foxp3+ population in the Dusp1/ recipi-
ents relative to WT hosts (Figure 7C). Thus, MKP-1 inhibits
in vivo Foxp3 induction of antigen-specific donor cells. To ascer-
tain whether this reflects direct effects mediated by MKP-1 in
DCs, we usedWT orDusp1/DCs to stimulate naive T cells iso-
lated from OT-II mice crossed with Foxp3gfp mice which express
green fluorescent protein regulated by the Foxp3 control
elements (Fontenot et al., 2005).WTDCs induced Foxp3 expres-
sion in a small subset of T cells in vitro, whereas Dusp1/ DCs
induced 2- to 3-fold more Foxp3+ T cells (Figure 7D). Therefore,
MKP-1 acts in DCs to inhibit T cell differentiation into iTreg cells.Immunity 35, 45–58, July 22, 2011 ª2011 Elsevier Inc. 53
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Figure 6. IL-12Rb2 and IL-23R Expression on T Cells Integrates MKP-1-Dependent Signals from DCs to Direct Th1 and Th17 Cell
Differentiation
(A) Kinetic analysis of IL-12Rb1, IL-12Rb2, IL-23R, and IL-6Ra mRNA in OT-II T cells stimulated with WT or Dusp1/ DCs.
(B) Expression of IFN-g and IL-17 in Il12rb2+/+ and Il12rb2/ T cells stimulated with WT or Dusp1/ DCs for 5 days and then restimulated with a-CD3 for 5 hr.
(C) Expression of IFN-g and IL-17 in OT-II T cells stimulated with WT or Dusp1/ DCs in the absence or presence of a-IL-23R blocking antibody for 5 days and
then restimulated with a-CD3 for 5 hr. Data are representative of two independent experiments (at least four mice per group).
Error bars indicate SEM.
Immunity
MKP-1 in DCs Instructs T Cell DifferentiationTGF-bplaysapivotal role tomediate iTregcell generation (Li and
Flavell, 2008). We therefore measured expression of TGF-b1-3 by
real-timePCRanalysis.WTandDusp1/DCsexpressedcompa-
rable levels of TGF-b1 and TGF-b3. In contrast, Dusp1/ DCs
expressed much higher levels of TGF-b2 (Figure 7E). Notably,
TGF-b2, but not TGF-b1 or TGF-b3, has been shown to be differ-
entially expressed between tolerogenic and immunogenic DCs
(Coombes et al., 2007). Consistent with the increased TGF-b2
expression fromDusp1/DCs, T cells culturedwith thesemutant
DCs showed stronger upregulation of p-SMAD3 (Figure 7F), a key
signal transducer to mediate TGF-b functions for iTreg cell gener-
ation (Liu et al., 2010; Tone et al., 2008). To examine the effect of
increased TGF-b2 production by Dusp1/ DCs, we added
a blocking antibody against TGF-b to T cells activated with WT
or Dusp1/ DCs. Such treatment blocked the increased Foxp3
expression induced by Dusp1/ DCs (Figure 7G). In addition to
TGF-b, IL-10 has also been shown to promote the generation of
Foxp3+ cells under selected conditions (Manicassamy et al.,
2009; Murai et al., 2009). Despite increased IL-10 in Dusp1/
DCs (Figure S4D), blocking IL-10 and IL-10R did not affect
Foxp3 expressionmediated byDusp1/ DCs (Figure 7G). There-
fore, MKP-1 inhibits DC-mediated iTreg cell generation mainly by
downregulating TGF-b2 expression.
Given the established roles of TGF-b in Th1 and Th17 cell
differentiation (Zhu et al., 2010), we further examined whether54 Immunity 35, 45–58, July 22, 2011 ª2011 Elsevier Inc.blocking TGF-b signaling affects MKP-1-dependent control of
these two populations. Interestingly, TGF-b blockade partially
enhanced Th1 but attenuated Th17 cell differentiation mediated
by Dusp1/ DCs (Figure S6A), suggesting that MKP-1-medi-
ated regulation of TGF-b2 partially contributes to Th1 and Th17
cell differentiation (Figure S6B).DISCUSSION
In the current paradigm of CD4+ T cell differentiation, cytokines
are considered as the most crucial factor to dictate cell fate
decision. These conclusions are largely based on the results
of stimulating T cells in vitro with copious amounts of cytokines
and varied combinations of cytokines and blocking antibodies,
and use of mice deficient in cytokines. Whereas such a
reductionist strategy is remarkably powerful in revealing how
cytokines regulate T cell lineage differentiation, it is unlikely to
recapitulate the intricate and complex interactions between
innate and adaptive immune systems that occur during physio-
logical processes of T cell priming. Dependence of T cell-medi-
ated adaptive immunity on innate signals has long been known
(Janeway, 1989), and identification of TLRs and other PRRs has
revolutionized our understanding of innate immune responses
(Kawai and Akira, 2010). However, it remains unclear how
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Figure 7. MKP-1 Inhibits Induction of iTreg Cells by Downregulating TGF-b2 Production from DCs
(A) Naive OT-II T cells (Thy1.1+) cells were transferred into WT and Dusp1/ mice and then immunized with OVA+CFA. Donor-derived cells in DLNs were
analyzed for the expression of Foxp3 after 7–8 days. Right, the proportion of Foxp3+ population in donor T cells.
(B) Analysis of Foxp3 and CTLA4 mRNA in cells as described in (A).
(C) Naive OT-II T cells (Thy1.1+) cells were transferred intoWT andDusp1/mice and then fedwithOVA in the drinkingwater for 5 days. Donor-derived cells in the
MLNs were analyzed for the expression of Foxp3. Right, the proportion of Foxp3+ population in donor T cells.
(D) Naive T cells from OT-II Foxp3gfp mice were stimulated with antigen and WT or Dusp1/ DCs for 5 days, followed by Foxp3-GFP analysis. Right, the
proportion of Foxp3+ population in CD4+ T cells.
(E) Analysis of TGFb-1-3 mRNA in WT and Dusp1/ splenic DCs after stimulation with LPS.
Error bars indicate SEM.
(F) Phosphorylation of SMAD3 in T cells stimulated with WT or Dusp1/ DCs.
(G) Foxp3 and CD25 expression in T cells stimulated with antigen and WT or Dusp1/ DCs in the absence or presence of a-IL-10 + aIL-10R and a-TGF-b
for 5 days.
Data are representative of four (A, B, E, F), two (C, G), and three (D) independent experiments (four to five mice per group). See also Figure S6.
Immunity
MKP-1 in DCs Instructs T Cell Differentiationkaleidoscopes of innate signals are integrated to shape T cell
lineages with distinct programs of gene expression and
functions.Although pathogen recognition begins at the PRR level, it
is the signaling components downstream of each receptor and
the way they interact with each other that ultimately determineImmunity 35, 45–58, July 22, 2011 ª2011 Elsevier Inc. 55
Immunity
MKP-1 in DCs Instructs T Cell Differentiationthe specific immunological outcome. By using mice lacking a
crucial negative regulator of MAPK activity, we have demon-
strated that T cell differentiation into multiple lineages is pro-
grammed at the level of DC intracellular signaling. Rather than
an all-or-none fashion as often observed in the present systems
of cytokine addition or ablation, MKP-1 acts in DCs to integrate
innate stimuli to cross-regulate differentiation of Th1, Th17, and
iTreg cell populations and to shape the balance among them.
Specifically, MKP-1 directs reciprocal Th1 and Th17 cell
differentiation by modulating IL-12 and IL-6 release from DCs
and the corresponding targets in T cells. Lack of MKP-1 in
innate immune cells disrupts antibacterial and fungal immune
responses andpromotes T cell-mediated inflammation in a colitis
model. Moreover, MKP-1 inhibits iTreg cell generation by down-
regulating the production of TGF-b2 from DCs. MKP-1 mediates
the DC-T cell crosstalk by imprinting multiple molecular targets
in T cells, including activation of STAT3, STAT4, and SMAD3
molecules, expression of cytokine receptors IL-12Rb2 and
IL-23R, and induction of lineage-specific transcription factors.
Altogether, MKP-1 signaling in DCs bridges innate and adaptive
immunity by programming ‘‘signal 3’’ to instruct distinct types of
T cell responses.
Adaptive immunity is controlled by PRR-induced signals at
multiple checkpoints that dictate the activation, effector class,
magnitude, duration, and memory of an adaptive immune
response (Palm and Medzhitov, 2009). Our findings indicate
that MKP-1-dependent pathway is a crucial determinant of the
specific class of adaptive immunity but is dispensable for the
initiation and magnitude of T cell responses. It is notable that
MKP-1 also limits PRR-triggered acute innate immune inflamma-
tion (Chi et al., 2006; Hammer et al., 2006; Salojin et al., 2006;
Zhao et al., 2006), suggesting that innate and adaptive immunity
is linked in DCs by MKP-1 signaling. Specifically, MKP-1 is
induced in innate immune cells to attenuate acute inflammation
and Th17 cell induction while promoting Th1 cell differentiation.
Therefore, MKP-1 represents a hitherto unappreciated pathway
that controls both processes triggered by PRRs—the acute
inflammation and induction of adaptive immunity. The concerted
interaction between the two arms of the immune systems might
have evolved as an important mechanism to maximize host
defense while minimizing damage to the host tissues.
Th1 and Th17 cells are known to both antagonize and coop-
erate in immune defense and tissue inflammation (Bending
et al., 2009; Lee et al., 2009; Martin-Orozco et al., 2009; Zhu
et al., 2010). In addition, developmental and functional plasticity
has also been observed between Th17 and iTreg cells (Bettelli
et al., 2006;Yangetal., 2008;Zhouet al., 2008) aswell asbetween
Th1 and iTreg cells (Liu et al., 2010). However, to our knowledge,
MKP-1 is the first signalingmolecule found in DCs to program the
differentiation of these diverse lineages.Why does T cell differen-
tiation into multiple lineages require coordinated regulation by
DC-derived signals? We propose that Th17 cell-inducing innate
stimuli (such as fungal infection) reduce MKP-1 expression and/
or elicit strong p38 activity in DCs (our unpublished findings) to
facilitate Th17 cell differentiation. Because Th17 cells cause
a rapid and potent neutrophilic inflammatory response, they run
a high risk of evoking the ‘‘collateral damage’’ to self tissues.
Therefore, concurrent downregulation of Th1 cell responses
and upregulation of iTreg cell differentiation are required to limit56 Immunity 35, 45–58, July 22, 2011 ª2011 Elsevier Inc.potential Th17 cell-mediated immunopathology. However,
excessive p38 activation resulting from MKP-1 deficiency can
lead toTh17cell-mediated inflammatory responses anddiseases
that override the counter-balancing actions of iTreg cell genera-
tion and Th1 cell downregulation. By contrast, a strong Th17
cell response is not induced by other pathogens such as intracel-
lular bacteria (probably to avoid unnecessary tissue damage);
rather, a stable, long-lived Th1 cell response is induced to facili-
tate pathogen clearance and establishment of immune memory
(Lee et al., 2009; Pepper et al., 2010), with the accompanying
development of iTreg cells to fine-tune the Th1 cell response
(Liu et al., 2010). Therefore, despite the observed reciprocal
development of several T cell lineages in vitro, differentiation of
CD4+ T cells does not simply follow a binary relationship. Instead,
it involves coordination of multiple lineages to establish a tightly
regulated balance between immune defense and tissue inflam-
mation and damage, with MKP-1 signaling in DCs functioning
as a critical determinant of T cell fates.
As a crucial factor to control multiple T cell lineage choices,
TGF-b is subjected to complex regulation. TGF-b is produced
as a latent form, and its activation in the immune system requires
DC-expressed integrin aVb8 (Lacy-Hulbert et al., 2007; Travis
et al., 2007), as well as T cell-expressed proprotein convertase
furin (Pesu et al., 2008). Although TGF-b1, but not TGF-b2 or
TGF-b3, was thought to be important for immune regulation
(Li and Flavell, 2008), it is notable that only the TGF-b2 isoform
is highly expressed in tolerogenic but not immunogenic DCs
(Coombes et al., 2007). How TGF-b production is regulated
in DCs remains elusive. Here we identify that TGF-b2 is upregu-
lated upon LPS stimulation, and its levels are negatively regu-
lated by MKP-1 in DCs. Moreover, our studies indicate that
DC-produced TGF-b2 is an important mechanism to mediate
iTreg cell generation.
In summary, MKP-1 programs DC-derived signal 3 to instruct
adaptive immune responses and cell fate determination among
Th1, Th17, and iTreg cells. Although T cell responses can be
influenced by the type of pathogens involved, the PRRs
engaged, and the specific subsets of responding DCs, our
results suggest that at the fundamental level, it is the intracellular
signaling pathways, especially those mediated by MKP-1 and
p38 MAPK, that integrate these diverse signals to imprint T cell
lineage choices.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6, CD45.1, Thy1.1, OT-II, Dusp1/, Rag1/, Il10/, Il12a/, and
Il12rb2/ mice were purchased from the Jackson Laboratory or described
previously (Chi et al., 2006). Foxp3gfp and 2D2 mice were kindly provided by
A. Rudensky and V. Kuchroo, respectively (Bettelli et al., 2003; Fontenot
et al., 2005). All mice had been backcrossed to the C57BL/6 background
and were used at 6–12 weeks old unless otherwise noted. BM chimeras
were generated by transferring 1–2 3 107 BM cells into lethally irradiated
mice (Liu et al., 2009). Animal protocols were approved by Institutional Animal
Care and Use Committee of St. Jude.
Adoptive Transfer and Antigen Challenge
Naive T cells (CD4+CD62LhiCD44loCD25) from OT-II TCR-transgenic mice
(Thy1.1+) were sorted and transferred into WT and Dusp1/ mice. After
24 hr, they were injected s.c. with OVA323-339 in the presence of Complete
Freund’s adjuvant (CFA; Difco), LPS (Invivogen), or curdlan (Wako Chemical).
Immunity
MKP-1 in DCs Instructs T Cell DifferentiationAlternatively, donor T cells were purified from 2D2 MOG-transgenic mice
(Thy1.1+), and after transfer, recipients were immunized with MOG35-55+CFA.
At day 7–8 after immunization, DLN cells were harvested and stimulated with
the cognate peptide for 2–3 days for cytokine mRNA and secretion analyses
or pulsed with PMA-ionomycin for 5 hr for intracellular staining for donor-
derived T cells (Thy1.1+). For oral antigen stimulation, after adoptive transfer
of naive OT-II T cells, mice were fed with water supplemented with 20 mg/ml
OVA protein (Grade VI; Sigma-Aldrich) for 5 days (Coombes et al., 2007; Liu
et al., 2010; Sun et al., 2007). For T cell transfer-induced colitis, 43 105 T cells
(CD4+CD45RBhiCD25) fromWTmicewere transferred intoDusp1/Rag1/
or Rag1/mice, and body weight was measured weekly (Liu et al., 2009).
Bacterial and Fungal Infections
For bacterial infection, mice were injected intravenously with 4 3 104
L. monocytogenes-expressing OVA. After 7–8 days, splenocytes were
harvested and stimulated with PMA-ionomycin or 1 mM LLO189-201 peptide
for 5 hr for intracellular staining or for 48 hr for RNA isolation. For fungal
infection, mice were injected intravenously with 23 105 live C. albicans yeast.
After 7–8 days, splenocytes were stimulated with 106/ml heat-killedC. albicans
for 2 days to measure cytokines secreted in the supernatant.
DC Cytokine Assays and Transfer
For in vivo DC cytokine assays, mice were injected i.p. with 0.5 mg/g LPS, and
after 5 hr, DCswere isolated from the spleens by Collagenase D (Roche) diges-
tion and sorted for RNA analysis. For in vitro DC cytokine assays, DCs were
stimulated with 100 ng/ml LPS for 5 hr for RNA analysis. For DC transfer,
splenic DCs were pulsed with 50 mg/ml OVA and 500 ng/ml LPS for 8 hr,
washed, and injected s.c. into C57BL/6 mice that had received naive OT-II
T cells 24 hr before. Mice were sacrificed 7–8 days later for analysis.
Cell Purification, Cultures, and Flow Cytometry
Spleens were digested with Collagenase D, and DCs (CD11c+TCR
CD19NK1.1) were sorted on a Reflection (i-Cyt). Lymphocytes were sorted
to enrich for naive T cells. For DC-T cell cocultures, DCs and T cells (1:10) were
mixed in the presence of 1 mg/ml OVA323-339 peptide and 100 ng/ml LPS or
other innate stimuli. After 5 days of culture, live T cells were stimulated with
PMA-ionomycin for intracellular cytokine staining or with plate-bound a-CD3
to measure cytokine secretion and mRNA expression. T cell proliferation
was determined by pulsing of cells with [3H] thymidine for the final 12–16 hr
of culture or by labeling with CFSE (carboxyfluorescein diacetate succinimidyl
diester; Invitrogen). For drug inhibitor treatments, cells were incubated with
vehicle, SB203580 (10 mM), or SP600125 (10 mM; both from Calbiochem) for
0.5–1 hr before stimulation. For antibody or cytokine treatment, cultures
were supplemented with 10 mg/ml a-TGF-b (1D11.16.8; Bio X Cell), a-IL-23R
(258010; R&D Systems), a-IL-6 (MP5-20F3; eBioscience), a-IL10 and
a-IL-10R (JES5-16E3 and 1B1.3a; eBioscience), or 1 ng/ml recombinant
IL-12 (BD Biosciences). Flow cytometry was performed with antibodies from
eBioscience or BD Biosciences.
RNA and Protein Analyses
Real-time PCR was performed with probe sets from Applied Biosystems and
normalized against the endogenous control gene HPRT (Liu et al., 2009).
Immunoblot was performed with the following antibodies: p-p38, p-JNK,
p-ERK, p-MKP-1, and p38 (all from Cell Signaling Technology), MKP-1 (Santa
Cruz), p-SMAD3 (Abcam), and b-actin (Sigma). The phosphatase activity
of MKP-1 was measured by incubating MKP-1 immunoprecipitates with
p-nitrophenyl phosphate, followed by measurement of absorbance at OD405,
as described (Brondello et al., 1999; Mercan and Bennett, 2010).
Statistical Analysis
p values were calculated with Student’s t test. p values of less than 0.05 were
considered significant. All error bars in graphs represent SEM calculated from
at least three replicates.
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